Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been newly diagnosed with a type of T-cell or NK/T-cell lymphoma or leukemia (a cancer affecting certain white blood cells), and have not yet received any treatment for it — specific types include conditions such as peripheral T-cell lymphoma, angioimmunoblastic T-cell lymphoma, anaplastic large cell lymphoma, extranodal NK/T-cell lymphoma, hepatosplenic T-cell lymphoma, and several other related types (confirm with trial site for the full list)
- You are 18 years of age or older
- A tissue sample (biopsy) was taken that is sufficient to confirm your diagnosis and can be sent for review by the trial team
- Your medical records include details about your disease at the time of diagnosis, your lab results, your treatment, and you are able to be followed up for at least 2 years
- You are able and willing to provide written consent to participate
Who may not be able to join:
- You have been diagnosed with certain other types of T-cell or NK-cell conditions, including Mycosis Fungoides, Sézary Syndrome, T-cell lymphoblastic lymphoma/leukemia, T-cell prolymphocytic leukemia, certain childhood-related T-cell/NK-cell diseases linked to a virus called EBV, or certain rare skin-related T-cell disorders
- You are under 18 years of age
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Massimo Federico, MD, University of Modena and Reggio Emilia, Centro Oncologico Modenese, Modena, Italy
Phone: +390594223284
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.